Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Basic Candlestick

Score

-0.35

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
SHORT 69 6.6 0.32% 0.46% 1.9% -1.6% -33.4%
LONG 70 5.8 0.59% 1.28% 1.9% -1.7% 23.6%

Summary

Technical Analysis

CSL (CSL.AX)


Indicator:

SHORT WHITE CANDLE


Last Signal:

BULLISH


Trading: BUY @ $227.4
Signal Strength: WEAK
Recommendation:

Indicator MUST BE USED in additional to another technical indicator to confirmation for trading position. Indicator can be applied to the short term timeframe but is only able to give and indication of the strength of the buyers versus sellers at the market close. This Japanese candlestick indicator can provide guidance on the short term battle between sellers and buyers from the companies recent trading.


CSL (ASX:CSL) has formed a Short White candlestick. This means, CSL has limited price movement derived from weak buying pressure. Given the limited timeframe in which signal has formed, further confirmation is required through volume and additional technical indicators.



This candlestick implies a relatively weak buying pressure with a limited price movement.

Calculation: Short White Candlestick:
1) The body of the candlestick is white and small.


PROFILE: CSL (CSL.AX)


Stock Exchange: ASX
Company: CSL
Ticker Codes: | CSL.AX | ASX:CSL |

About CSL (ASX:CSL):

CSL Limited engages in the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, and internationally. It operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of bleeding disorders, including hemophilia and von Willebrand disease, primary and secondary immunodeficiency's, hereditary angioedema, neurological disorders, and inherited respiratory diseases. Its products are also used to prevent haemolytic diseases in newborns and infections in solid organ transplant recipients, as well as specific infections; and for urgent warfarin reversal in patients with acute major bleeding, as well as victims of trauma, shocks, and burns. In addition, this segment operates approximately 180 human blood plasma collection centers. Further, it conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and offers influenza vaccines. It also provides in-licensed vaccines and specialty pharmaceuticals; manufactures and markets diagnostics for immunohematology laboratories; and supplies a range of products, including antivenoms and Q fever vaccines. The company was founded in 1916 and is headquartered in Parkville, Australia.

Top 10:

Basic Candlestick

Download
Company Close Change(%) Volume Value Signal
CCP Credit Corp 27.27 13.3 452,171 0 BULLISH
ATL ASX 20 0.43 10.4 117,204 0 BULLISH
SUL Super Cheap Auto 9.75 7.9 2,023,965 1 BULLISH
SGR The Star Entertainment 3.79 5.9 14,342,914 0 BULLISH
AHG Advance Healthcare 3.21 4.6 663,989 0 BULLISH
SHM Shriro 0.67 3.9 91,198 0 BULLISH
CYB Cybg 2.48 3.8 5,776,731 0 BULLISH
CAT Catuity 1.17 3.6 340,110 1 BULLISH
APZ Aspen 1.09 3.3 9,720 0 BULLISH
ORA Orora 2.77 3 19,003,657 1 BULLISH